G lucagon-like peptide-1 receptor agonists, aka GLP-1 agonists, such as semaglutide -- better known as Ozempic -- have ...

GLP-1 therapy is a groundbreaking approach in the treatment of obesity and metabolic health issues. GLP-1, or glucagon-like ...

GLP-1 drugs like Ozempic can help kidney transplant patients avoid organ failure and live longer, a new study sugges ...

Dr. Troy Mensen is a family medicine doctor based in the Chicago area. He completed his undergraduate degree at the University of Northern Iowa and his doctorate at Des Moines University College ...

Recipe photos: Morgan Hunt Glaze and Jen Causey. EatingWell design.

They do this by mimicking a hormone called glucagon-like peptide 1, or GLP-1. GLP-1 binds to receptors in the pancreas and ...

Some GLP-1 users also report fewer cravings for unhealthy ... “The fact that we know these medicines work in the brain and the pancreas and they’re so effective is proof that it’s a ...

Kidney transplant recipients with type 2 diabetes treated with a new class of anti-obesity drugs were less likely to experience organ failure and survived longer, a new study shows.

which include inflammation in the pancreas and liver problems. There had also been concern that GLP-1 agonists might increase the risk for a rare form of thyroid cancer in patients already taking ...

Amylin is a pancreas-related hormone that ... Survodutide is an injectable drug that activates both the glucagon and GLP-1 receptors. According to Nature, the drug is predicted to be available in 2027 ...